E-Paper
Merck to sell generics to Mylan for 4.9 bn euros
German drugs and chemicals group Merck KGaA said it had signed a share purchase agreement with Mylan Laboratories Inc under which the US firm will acquire its generics business for 4.9 bn euros.
Updated on: May 13, 2007, 16:15:19 IST
Share via
Copy link
German drugs and chemicals group Merck KGaA said on Sunday it had signed a share purchase agreement with Mylan Laboratories Inc under which the US firm will acquire its generics business for 4.9 billion euros.
Merck said the agreement was subject to regulatory approval and that it expected the transaction to close in the second half of 2007.
Follow India news real-time updates and the latest news covered on Hindustan Times, featuring today's critical updates on Sonam Wangchuk LIVE and more across India.
